Cidara Therapeutics Inc buy BiotechBee
Start price
21.09.22
/
50%
€0.78
Target price
30.04.23
€3.00
Performance (%)
87.12%
End price
06.02.23
€1.46
Summary
This prediction ended on 06.02.23 with a price of €1.46. With a performance of 87.12% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cidara Therapeutics Inc | -15.584% | -15.584% | -33.480% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% |
According to BiotechBee what are the pros and cons of Cidara Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cidara Therapeutics Inc diskutieren
In the thread Trading Cidara Therapeutics Inc
Stopped prediction by BiotechBee for Cidara Therapeutics Inc
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.43
06.02.23
06.02.23
€3.00
31.12.25
31.12.25
-35.87%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
